Curanex Pharmaceuticals Inc
CURX
Last
$5.31
Day
+13.0%
1y
+544.1%
5y
+18.4%
52w
-30.0%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1333d
EMA 21
4.60
EMA 50
3.64
EMA 200
1.93
20d high
-10.0%
5y high
-48.1%
5y range
51th
Positions held
Your positionsCURX isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
23
Hold
swing
Signal
Buy
Target
$6.03
Stop
$4.13
Stop distance
22.2%
Target vs last
+13.6%
Fundamentals
| Market cap | $7.46M | Enterprise value | $4.80M | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | 1.41 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -4.1% | ROA | -2.3% | Debt / equity | 0.06 |
| Current ratio | 45.95 | Free cash flow | -$7.71M | Analyst recommendation | none | Mean target | — |
| 52w high | $16.94 | 52w low | $3.58 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$3.3M | -$3.2M | -$3.1M | -$1.0M | -$0.1M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$3.3M | -$3.2M | -$3.1M | -$1.0M | -$0.1M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | -77.8% |
| Net income | -$4.2M | -$0.4M | -$0.0M | -$0.0M |
| Gross margin | — | — | — | 17.0% |
| Gross profit | — | — | $0.0M | $0.0M |
| Operating income | -$4.2M | -$0.3M | -$0.0M | -$0.0M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
No headlines.
Price (daily)
Full chart · RSI · MACD · patternsCURX · daily+3.9% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin